Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
- PMID: 32601254
- PMCID: PMC7828891
- DOI: 10.1503/cmaj.76023
Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
Conflict of interest statement
Competing interests: Richard Henry has filed a provisional patent: Use of mineralocorticoid blockers in the treatment of COVID-19.
Comment on
-
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17. Circ Res. 2020. PMID: 32302265 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical